01209nam a2200313 c 4500001001300000005001500013007000300028008004100031020002500072049003200097052001800129056001500147074002500162082001400187245015400201260005500355300004200410490003200452504002400484650005900508700006100567700002200628830005900650880005700709880005600766880002800822880002800850950001700878KMO20204158920200925134733ta200714s2019    ulkad         000   korAG  a9788956913308g935100 lEM7652931lEM7652932c2fGP01a518.501b20-6  a518.50126  k11-1040350-000209-0101a615.7223006880-01a의약품 안전관리체계 실태조사 :b시판허가 이후 단계를 중심으로 /d연구책임: 최슬기 ;e공동연구: 윤석준  6880-02a서울 :b감사원 감사연구원,c2019  aiii, 39 p. :b삽화, 도표 ;c26 cm10a연구보고서 ;v2019-029  a참고문헌 수록 8a의약품 안전성[醫藥品安定性]0KSH19980390091 6880-03a최슬기,g崔璱暣,d1982-0KAC2018C91124aut1 6880-04a윤석준 0a연구보고서(감사원 감사연구원) ;v2019-029006245-01/(BaUiyakpum anjeon gwalli chegye siltae josa  6260-02/(BaSeoul :bGamsawon Gamsa Yeonguwon,c20191 6700-03/(BaChoe, Seulgi1 6700-04/(BaYun, Seokjun1 a가격불명